Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research

/in , , , /by

Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a Targeted Approach for Immunotherapy Research Hercules, CA — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research. Messenger molecules such as cytokines […]

Read more →

TGR BioSciences acquired by Sygnis AG (now Expedeon AG)

/in , /by

Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the completion of the acquisition of TGR Biosciences (TGR), the Australian research reagents company. TGR and its highly complementary technologies and products along with its strong customer base will significantly contribute to the overall performance of the SYGNIS Group. SYGNIS […]

Read more →

The Native Antigen Company Signs Distribution Agreement with BIOZOL and Shanghai Bioleaf

/in , , , /by

Sole distributor agreements covering Germany, Switzerland, Austria and China will improve access to high-quality viral and bacterial antigens, antibodies and immunoassay research reagents   Oxford, UK: The Native Antigen Company, one of the world’s leading suppliers of reagents that enable research into vaccine development and diagnostics for emerging and endemic infectious diseases, announced today that it […]

Read more →

Frank Schestag, PhD, Joins Proteintech as Commercial Director in Europe

/in , , , /by

ROSEMONT, Ill. Proteintech, the benchmark in antibodies and proteins, welcomes Frank Schestag, PhD, as Commercial Director. He will be providing leadership to the sales and marketing teams and growing the markets in Germany, Austria, and Switzerland. Dr. Schestag comes to Proteintech with 18 years of experience in sales and management of scientific reagents and equipment. […]

Read more →

Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less

/in , , , /by

CAMBRIDGE (UK) – Antibodies.com, a digital marketplace that enables life scientists to purchase critical research reagents at cost-effective prices from the primary manufacturers, today announced that is has raised £400,000 in pre-seed financing. Nidobirds Ventures, after successful investment in Labstep, joined local angel investors and industry veterans in the funding round. The funds will be […]

Read more →

New ambr® 250 Modular Bioreactor Vessel Launched for Cell and Gene Therapy Applications

/in , /by

New vessel is designed for gentle stirring and optimum growth of cell lines Cost-effective, scalable process development of cell and gene therapies   Goettingen, GER | Royston, UK: Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry, today launched a new vessel for its ambr® 250 modular benchtop automated mini bioreactor system. The single-use vessel […]

Read more →

QUANTERIX ANNOUNCES AGREEMENT TO ACQUIRE UMANDIAGNOSTICS, WORLD’S LEADING NEUROFILAMENT LIGHT (NF-L) ANTIBODY SUPPLIER

/in , , , /by

Positions Quanterix to capitalize on significant growth opportunities with Nf-L applications in Alzheimer’s Disease, Multiple Sclerosis, and other neurodegenerative conditions Provides expected 200 bps of annualized company gross margin improvement, before impact of purchase price accounting, and expected to accelerate cashflow breakeven timing Strengthens Quanterix’ assay development and supply capabilities Secures Nf-L antibody supply critical to Quanterix’ […]

Read more →

BenchSci Announces Total Funding of $27.2 Million as Gradient Ventures Increases Investment, Helping to Meet Demand for Toronto Company’s AI Drug Discovery Technology

/in , , , /by

Leader in biomedical machine learning will use additional funds to expand Toronto office, Toronto team, and global salesforce to service growing pharmaceutical customer base TORONTO BenchSci today announced additional investment from Gradient Ventures, Google’s AI-focused venture fund, that brings the company’s total funding to CAD $27.2 million (USD $20.5 million). BenchSci will use the additional […]

Read more →

PerkinElmer Expands Portfolio of Grain Mycotoxin Testing Solutions with New Corn Aflatoxin Strip Test

/in , /by

AuroFlow AQ Afla™ Strip Test Delivers Accurate In-Field or Lab Results in Six Minutes WHAT:  PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its AuroFlow™ AQ Afla strip test, which helps lab professionals, technicians and farmers quickly and accurately conduct first-round screening for toxic compounds in corn. The strip test, used with PerkinElmer’s QuickSTAR™ […]

Read more →

Human Glycome Project Boosted by Support of Critical Goods and Services from Genos, New England Biolabs and Waters Corporation

/in , , , /by

ZAGREB, Croatia and IPSWICH, Mass. and MILFORD, Mass. — The Human Glycome Project,  Genos®, New England Biolabs® (NEB®) and Waters™ Corporation today announced a collaboration to accelerate glycomics research by providing goods and services critical to glycan analysis. Launched in October 2018, the Human Glycome Project is a global initiative to map the structure and function of human glycans. The completion of […]

Read more →